We are live on
!
Find out more
PAWC
P.A.W. Capital Portfolio holdings
AUM
$36.7M
1-Year Est. Return
6.81%
This Fund
S&P 500
This Quarter
Est. Return
+6.81%
1 Year Est. Return
-6.81%
3 Year Est. Return
-2.78%
5 Year Est. Return
-4.97%
10 Year Est. Return
+711.77%
AUM
$92.5M
AUM Growth
-$8.6M
(-8.5%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-12.08%
Top 10 Holdings %
Top 10 Hldgs %
40.67%
Holding
70
New
7
Increased
12
Reduced
18
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareCloud
CCLD
|
+$2.22M |
| 2 |
Ambarella
AMBA
|
+$1.79M |
| 3 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$1.34M |
| 4 |
EverQuote
EVER
|
+$1.25M |
| 5 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$695K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMLR
Semler Scientific
SMLR
|
+$1.37M |
| 2 |
Krystal Biotech
KRYS
|
+$1.15M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$863K |
| 4 |
PVLA
Palvella Therapeutics
PVLA
|
+$838K |
| 5 |
Chegg
CHGG
|
+$754K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.34% |
| 2 | Healthcare | 19.69% |
| 3 | Communication Services | 16.88% |
| 4 | Consumer Staples | 8.59% |
| 5 | Industrials | 6.74% |
Similar funds
ICP
RH
CI
GC
FC
CM
BAM
AP
P.A.W. Capital's Q2 2019 Portfolio in Review
As of Q2 2019, P.A.W. Capital held 70 positions worth $92.5M, down 8.5% from $101M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
P.A.W. Capital withdrew a net $11.2M in Q2 2019, closing 7 positions and reducing 18 holdings. Its most notable exit was Semler Scientific, an estimated $1.37M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, P.A.W. Capital opened a new position in CareCloud worth $2.27M.
- P.A.W. Capital's largest Q2 2019 buy was CareCloud: 450,000 shares worth $2.27M.
- P.A.W. Capital added most to EverQuote in Q2 2019, an estimated $1.25M increase.
- P.A.W. Capital's biggest Q2 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $863K.
- P.A.W. Capital fully exited Semler Scientific in Q2 2019, selling an estimated $1.37M.
- P.A.W. Capital's ten largest holdings make up 41% of its $92.5M portfolio in Q2 2019.
- P.A.W. Capital opened 7 new positions and closed 7 in Q2 2019.
- P.A.W. Capital's portfolio value fell 8.5% quarter-over-quarter to $92.5M.
Based on P.A.W. Capital's 13F filing for Q2 2019, filed 31 Jul 2019.